New Skåne study to slow down type 1 diabetes
Published 20 May 2021 In type 1 diabetes, the patient’s own immune system destroys the body’s insulin-producing cells. Researchers at Region Skåne and Lund University are leading a new drug study aimed at halting the immune system’s attack and preserving residual cells in newly diagnosed adults. The new study, dubbed IMPACT, will last a year and be It is aimed at people between the ages of 18 and
https://www.medicine.lu.se/article/new-skane-study-slow-down-type-1-diabetes - 2025-04-03